Eli Lilly and Co. halts Alzheimer’s drug production
Eli Lilly and Co., a pharmaceutical company based in Indianapolis, began research for a breakthrough Alzheimer’s treatment in 2008. Last week, The New York Times reported that Eli Lilly had stopped phase three clinical trials.






